id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-261311-j6bmgmhz	Parreiras Martins, Maria Auxiliadora	Preparedness of pharmacists to respond to the emergency of the COVID-19 pandemic in Brazil: a comprehensive overview	2020-07-31		.txt	text/plain	4312	165	32	Rev Bras Ter Intensiva Liver and kidney injuries in COVID-19 and their effects on drug therapy; a letter to editor COVID-19 and older adults: what we know New understanding of the damage of SARS-CoV-2 infection outside the respiratory system Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy A proposal for staging COVID-19 coagulopathy Heparin: effects upon the glycocalyx and endothelial cells The versatile heparin in COVID-19 Stratifying therapeutic enoxaparin dose in morbidly obese patients by BMI class: a retrospective cohort study Guidance on minimizing risk of drug-induced ventricular arrhythmia during treatment of COVID-19: a statement from the Canadian Heart Rhythm Society Antibiotic use in the intensive care unit: optimization and de-escalation COVID-19: the uninvited guest in the intensive care unit (ICU) implications for pharmacotherapy COVID-19 and the potential long-term impact on antimicrobial resistance Involving antimicrobial stewardship programs in COVID-19 response efforts: all hands on deck Coronavirus disease 2019 (COVID-19) and pregnancy: what obstetricians need to know Hyperinflammatory shock in children during COVID-19 pandemic Breastfeeding and respiratory antivirals: coronavirus and influenza COVID-19 and cancer: a comprehensive review A standardized, structured approach to identifying drug-related problems in the intensive care unit: FASTHUG-MAIDENS Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia Prediction models for diagnosis and prognosis of COVID-19 infection: systematic review and critical appraisal The laboratory tests and host immunity of COVID-19 patients with different severity of illness Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19 Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease COVID19 coagulopathy in Caucasian patients Atrial fibrillation: prevalence in a large database of primary care patients in Brazil Acknowledgements COVID-19 patients may present high risk in the use of medications and clinical pharmacists can contribute substantially as part of a multidisciplinary team to improve outcomes in drug therapy in severe and critical illness.	cache/cord-261311-j6bmgmhz.txt	txt/cord-261311-j6bmgmhz.txt
